Table 3.
Univariate and multivariate analyses of OS, PFS, and PPS.
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p Value | HR | 95% CI | p Value | |
| (a) OS | ||||||
| Period A | 1.00 | – | – | 1.00 | – | – |
| Period B | 0.87 | 0.74–1.02 | 0.089 | 0.89 | 0.76–1.04 | 0.142 |
| Period C | 0.75 | 0.64–0.87 | <0.001 | 0.77 | 0.66–0.91 | 0.002 |
| Period D | 0.63 | 0.54–0.75 | <0.001 | 0.64 | 0.53–0.76 | <0.001 |
| (b) PFS for first-line chemotherapy | ||||||
| Period A | 1.00 | – | – | 1.00 | – | – |
| Period B | 0.95 | 0.81–1.12 | 0.089 | 0.96 | 0.81–1.13 | 0.621 |
| Period C | 0.75 | 0.64–0.88 | <0.001 | 0.76 | 0.64–0.89 | <0.001 |
| Period D | 0.68 | 0.58–0.80 | <0.001 | 0.68 | 0.58–0.81 | <0.001 |
| (c) PPS for first-line chemotherapy | ||||||
| Period A | 1.00 | – | – | 1.00 | – | – |
| Period B | 0.83 | 0.70–0.97 | 0.023 | 0.84 | 0.71–1.00 | 0.044 |
| Period C | 0.81 | 0.69–0.95 | 0.008 | 0.87 | 0.74–1.03 | 0.100 |
| Period D | 0.74 | 0.63–0.88 | <0.001 | 0.76 | 0.64–0.91 | 0.003 |
CI, confidence interval; HR, hazard ratio; OS, overall survival; PFS, progression-free survival; PPS, post-progression survival.